why choose us

First received: June 06, 2023

Clinical Trial: Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for High-risk Stage II/III Colorectal Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: High-risk Stage II Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for High-risk Stage II/III Colorectal Cancer: a Multicenter, Prospective, Randomized Controlled Cohort Study (FIND Trial)

Brief Summary: Colorectal cancer (CRC) is one of the most common gastrointestinal tumors.According to the latest cancer report, the incidence and mortality rates of CRC are both ranked top 5 among malignant tumors worldwide and continue to rise.Patients who receive treatment in the early stage (stage I) have a 5-year survival rate of approximately 90%.However, for high-risk stage II and III colorectal cancer patients, the 5-year survival rate is only 40%-70%, and almost half of the patients experience postoperative recurrence…

Read more